CHEM-X-INFINITY partnered with XANCHEM to produce libraries around original scaffolds. The compounds will be of particular interest in the oncology field.

CHEM-X-INFINITY partnered with ORIBASE PHARMA to offer kinase focused libraries. The compounds are built around several small aza-heterocycles underused in combinatorial libraries and will have applications in the oncology field.

CHEM-X-INFINITY will attend the 18th Molecular Medicine Tri-Conference on February 23rd-25th, 2011 in San Francisco, CA.

The SCT Annual Workshop in Medicinal Chemistry was held the 7th of December in Paris at the Faculté de Médecine Cochin Port-Royal in collaboration with GFPP. Please read in this news our feeling about the event.

CHEM-X-INFINITY partnered with DIVERCHIM to design and produce original libraries from synthetic analogues of natural compounds. The compounds will be of particular interest in the oncology field.

CHEM-X-INFINITY attended the 21st International Symposium of Medicinal Chemistry on September 5th-9th, 2010, in Brussels, Belgium. Please read in this news our feeling about the event.

CHEM-X-INFINITY is pleased to announce a new library focused on kinases, DNA processing enzymes and GPCRs. The original azaindole scaffold could be useful for the identification of new potent series. The library was co-designed with Provence Technologies which is a company specialized in the synthesis of azaindoles.

CHEM-X-INFINITY is pleased to announce a new library focused on proteases. Two versatile linkers have been used to synthesize compounds able to interact with serine and cysteine residues of proteins. The compounds could also have applications in GPCRs and antibiotics.

CHEM-X-INFINITY released a new focused library centered on the linker dialkylaminoamide. This versatile linker can be found in various active molecules targeting enzymes, ion channels and GPCRs. A selection of potent peptidomimetic structures is also presented.

CHEM-X-INFINITY is pleased to announce that it has received the accreditation for the French R&D tax credit for years 2009 to 2012. The system allows French companies to have a tax credit for R&D services outsourced in approved companies.